Home >> CAP TODAY Webinars On-Demand >> Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients

Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients

image_pdfCreate PDF

Dr. Harada

Dr. Chandrashekar

Dr. MacKinnon

Webinar presenters Alexander Craig MacKinnon, Jr, MD, PhD, Professor, Department of Pathology, University of Alabama at Birmingham, Darshan Chandrashekar, PhD, Assistant Professor, Department of Pathology-Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham, and Shuko Harada, MD, Professor, Department of Pathology-Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham, discuss rapid biomarker identification and how it promises more comprehensive approaches, including an FDA cleared solution with a clear path to reimbursement; how professional services with dedicated project management offer a streamlined path to implementation; and how sample and data ownership opens up avenues to explore research opportunities.

This on-demand webinar originally broadcast December 5, 2023.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Labcorp.

CAP TODAY
X